Soluble Sanitising Wet Wipe

Using soluble, sanitising, wet wipes in clean rooms to eliminate infection,  avoid the risks of conventional disposal methods and cross contamination and empower individuals to avoid exposure and lessen transmission.  

.  

Brian McCormack is an entrepreneur and founder of McCormack Innovation.

For this solution the Team Lead is Garry Crighton, a co-director with experience in HSEQ and Business Management Systems. 

We are addressing the specific problem of how communities around the world prepare for and respond to emerging pandemics and health security threats. 

Current (non soluble) sanitising wet wipes are used in hospitals and clinic clean rooms to sanitise patients, equipment and surfaces. 

These used and often contaminated wipes have to be handled by various parties over and above the user / clinician – increasing risk of cross contamination. and that need to be disposed of using costly and complex, hazardous materials collection and disposal protocols. 

Our target audience are those whose lives are at risk in hospitals and clinics but also to provide added protection in the home. 

This includes patients, doctors, nurses, cleaners and other key workers who handle wet wipes that are currently disposed of via landfill streams. 

To further understand the needs of our target population we are currently developing a digital platform (development of our website and set up of social media channels) that will more readily involve our key players. 

With more insight from that platform we will be in an ever stronger position to effectively address those needs. 

The introduction and roll out of our soluble sanitising wipes in clean room settings will revolutionise the current more risky protocols. 

The resultant enhanced protection of patients and hospital staff and all other aspects of the community, will provide the most extraordinary public good. 

With our plans to take this globally at prices competitive with currently available non soluble wipes, we have a solution that will provide huge benefits to the well being of the public at large. 

With a leading healthcare company we already have the capacity to reach UK, Irish, Norwegian and Australian stoma care markets. 

For our soluble, sanitising wipes we are already in discussions with other global manufacturers and distributors of wet wipes in the US and European markets.  

In the UK we are in discussions with the NHS, England to commence trials of our product. 

Over the next three years, following the business model that was used successfully with a leading healthcare partner, our objective and expectation is to have similar agreements in place with a number of global manufacturers and distributors. 

With direct interest from NHS, England we see the use of our soluble sanitising wipes in hundreds of medical facilities around the country which will a transformational impact on millions of lives. 

For our soluble wet wipes, our targeted market segments are existing Wet Wipes Manufacturers/Suppliers, Health Care Distributors and User Groups. 

We continue to research what customers value, such as product features, quality, image or customer service and are continuously making adjustments to the product life cycle to increase profitability.  

Key market trends and the characteristics and size of this market segment is described in our Revenue Projection for Sales. This constitutes a key performance indicator for measuring our success. 

For what is only the second year of this project we have already exceeded our expectations and with our ongoing marketing strategy we are confident that our impact goals will continue to be realised.  

The barriers and the minimum requirements to overcome each barrier are as follows:

Marketing reach, distribution and awareness/Development of a digital platform and completion of a branding and design project 

Partnerships, agencies and distribution/Ongoing marketing and commercialisation of the business and its products. 

Cash flow/start up cash drain/More licensing agreements and the growth of existing income streams.

Fruedenburg, Germany 

A leading healthcare company, UK

Water UK/WRC, UK

Impact Solutions, UK 

Johnsons - Chartered Patent and Trademark Attorneys 

Brodies - Solicitors 

EQ Chartered Accountants 

Beyond any fund raising ambitions, the Trinity Challenge and its membership organisations present a huge, opportunistic, platform for sharing, promotion and support of our company and its solutions. 

We see that the Trinity Challenge can be of assistance in bringing global attention of our solution to public health experts, government agencies, etc., and so help in overcoming the following aforementioned barriers;

Marketing reach, distribution and awareness

Partnerships, agencies and distribution

Cash flow/start up cash drain

For reasons of sharing and promoting our solutions, we would like to partner with the following entities;

- Bill and Melinda Gates Foundation 

- Global Virome Project 

- Optum

- Reckitt Benckiser

- BD

- Clinton Health Access Initiative

- Doctor Evidence